Komori
Presentation materials for financial results6323RORZE CORPORATIONMachinery

Financial Results Presentation for the Second Quarter of the Fiscal Year Ending February 2027 (42nd Fiscal Year)

In response to a sharp increase in orders for semiconductor-related equipment, the company revised upward its full-year forecasts for net sales, operating profit, ordinary profit and net income for the fiscal year ending February 2027. The year-end dividend forecast was also increased from ¥20 to ¥28 per share.

Worth reading
69In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Improvement
Direction inferred from the company’s description.
Scale
20985
¥ million (increase in full-year revenue forecast)
Wording
Conditional
How definitive the wording is.

Contents of this document

Presentation materials for financial resultsFiscal year ending February 2027, second quarter8 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥79,733 million+21.5%
Operating profit¥23,096 million+42.4%
Ordinary income¥24,538 million+68.4%
Net income¥15,839 million+45.7%
Operating profit margin29 %
Results for the three months of the current quarter
Net Sales
¥42,524 million
Operating profit
¥12,866 million
Segment revenue
Semiconductor-related equipment
¥36,898 million
Analytical instruments
¥414 million
FPD-related equipment
¥1,904 million
Life science-related equipment
¥245 million
Parts, repairs and other
¥3,063 million
Full-year earnings forecast
Net Sales
¥180,007 million
Operating profit
¥53,078 million
Ordinary income
¥54,889 million
Profit attributable to owners of the parent
¥37,779 million
Semiconductor-related equipment revenue
¥152,970 million
Analytical equipment revenue
¥3,490 million
FPD-related equipment revenue
¥7,349 million
Life sciences-related equipment revenue
¥1,616 million
Revenue from parts repairs and other
¥14,579 million
Progress against full-year forecast　通期の予想に対して、いまどこまで進んだかの割合です。
Net Sales44.3
Semiconductor-related equipment43.9
Analytical instruments37.4
FPD-related equipment53.6
Life science-related equipment23.3
Parts repairs and other47.9
Operating profit43.5
Ordinary income44.7
Profit attributable to owners of the parent41.9
What the company explained in this material
Breakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
Change in operating income from the previous quarter
Revenue Volatility2,117
Foreign Exchange Effects173
Personnel Expenses-53
Research and development costs-12
Amortization of goodwill0
Other SG&A expenses378
Assumptions Underlying the Business OutlookThe assumptions used by the company in preparing its forecast.
Average exchange rate during the period
158 JPY/USD
New initiatives
  • Accelerated hiring and expansion of the production area at the Vietnam plant
  • The planned start of operations at the new Vietnam plant was changed from Q1 2028 to Q4 2027
  • Transition to two-shift operations and leasing of a new building at the Shanghai Lingang plant in China
  • Advance ordering of materials and securing inventory, as well as securing alternative parts and suppliers
Key KPIsA metric the company considers important as a management benchmark.
  • Orders for semiconductor-related equipment¥78,509 million
    Year on year against the same period last year3.2x
  • Order backlog for semiconductor-related equipment¥103,863 million
    Year on year against the same period last year2.3x
  • Orders for analytical equipment¥1,346 million
  • Order backlog for analytical equipment¥5,604 million
  • Orders for FPD-related equipment¥1,995 million
  • Order backlog for FPD-related equipment¥1,127 million
Segment results
Semiconductor-related equipment
Net Sales
¥67,138 million
Year on year against the same period last year+22.8%
Analytical instruments
Net Sales
¥1,304 million
Year on year against the same period last year-9.4%
FPD-related equipment
Net Sales
¥3,936 million
Year on year against the same period last year+20.8%
Life science-related equipment
Net Sales
¥376 million
Year on year against the same period last year+2.8%
Parts, repairs and other
Net Sales
¥6,977 million
Year on year against the same period last year+18.5%
Orders received and order backlog
Semiconductor-related equipment
Orders received
¥78,509 million
Order backlog
¥103,863 million
Analytical instruments
Orders received
¥1,346 million
Order backlog
¥5,604 million
FPD-related equipment
Orders received
¥1,995 million
Order backlog
¥1,127 million
Number of employees
Number of Employees4,466 People
Record dateEnd of August 2026
Change during the periodUp 43 people from 4,423 in FY2026 Q1
Annual Dividend
End of period
¥28 per share
Contents of this document
ItemDetails
Document typePresentation materials for financial results
Fiscal Period CoveredFiscal year ending February 2027, second quarter
Net Sales¥79,733 million (YoY +21.5%)
Operating profit¥23,096 million (YoY +42.4%)
Ordinary income¥24,538 million (YoY +68.4%)
Net income¥15,839 million (YoY +45.7%)
Operating profit margin29 %
Results for the three months of the current quarterNet Sales ¥42,524 million / Operating profit ¥12,866 million / Segment revenue Semiconductor-related equipment ¥36,898 million / Analytical instruments ¥414 million / FPD-related equipment ¥1,904 million / Life science-related equipment ¥245 million / Parts, repairs and other ¥3,063 million
Full-year earnings forecastNet Sales ¥180,007 million / Operating profit ¥53,078 million / Ordinary income ¥54,889 million / Profit attributable to owners of the parent ¥37,779 million / Semiconductor-related equipment revenue ¥152,970 million / Analytical equipment revenue ¥3,490 million / FPD-related equipment revenue ¥7,349 million / Life sciences-related equipment revenue ¥1,616 million / Revenue from parts repairs and other ¥14,579 million
Progress against full-year forecastNet Sales 44.3 / Semiconductor-related equipment 43.9 / Analytical instruments 37.4 / FPD-related equipment 53.6 / Life science-related equipment 23.3 / Parts repairs and other 47.9 / Operating profit 43.5 / Ordinary income 44.7 / Profit attributable to owners of the parent 41.9
Segment resultsSemiconductor-related equipment Net Sales ¥67,138 million / Year on year against the same period last year 22.8 / Analytical instruments Net Sales ¥1,304 million / Year on year against the same period last year -9.4 / FPD-related equipment Net Sales ¥3,936 million / Year on year against the same period last year 20.8 / Life science-related equipment Net Sales ¥376 million / Year on year against the same period last year 2.8 / Parts, repairs and other Net Sales ¥6,977 million / Year on year against the same period last year 18.5
Breakdown of Factors Affecting the ChangeChange in operating income from the previous quarter Revenue Volatility 2,117 / Foreign Exchange Effects 173 / Personnel Expenses -53 / Research and development costs -12 / Amortization of goodwill 0 / Other SG&A expenses 378
Key KPIsIndicator name Orders for semiconductor-related equipment / Value ¥78,509 million / Year on year against the same period last year 3.2x, Indicator name Order backlog for semiconductor-related equipment / Value ¥103,863 million / Year on year against the same period last year 2.3x, Indicator name Orders for analytical equipment / Value ¥1,346 million / Year on year against the same period last year Not disclosed, Indicator name Order backlog for analytical equipment / Value ¥5,604 million / Year on year against the same period last year Not disclosed, Indicator name Orders for FPD-related equipment / Value ¥1,995 million / Year on year against the same period last year Not disclosed, Indicator name Order backlog for FPD-related equipment / Value ¥1,127 million / Year on year against the same period last year Not disclosed
Number of employeesNumber of Employees 4,466 People / Record date End of August 2026 / Change during the period Up 43 people from 4,423 in FY2026 Q1
Assumptions Underlying the Business OutlookAverage exchange rate during the period 158 JPY/USD
Annual DividendAnnual Not disclosed / Interim Not disclosed / End of period ¥28 per share
Orders received and order backlogSemiconductor-related equipment Orders received ¥78,509 million / Order backlog ¥103,863 million / Analytical instruments Orders received ¥1,346 million / Order backlog ¥5,604 million / FPD-related equipment Orders received ¥1,995 million / Order backlog ¥1,127 million
New initiativesAccelerated hiring and expansion of the production area at the Vietnam plant, The planned start of operations at the new Vietnam plant was changed from Q1 2028 to Q4 2027, Transition to two-shift operations and leasing of a new building at the Shanghai Lingang plant in China, Advance ordering of materials and securing inventory, as well as securing alternative parts and suppliers
Items this document does not state (13)
Gross Profit MarginSelling, general and administrative expensesSelf-assessment against the planUnit price and quantity metricsNumber of stores and locationsRisk amount incorporated into the outlookMedium-term management plan targetsFinancial targetsPayout ratioAcquisition of treasury sharesCapital expendituresMarket Size / ShareKey points of the Q&A

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Because orders for semiconductor-related equipment increased sharply. The increases in operating profit and ordinary profit were also supported by higher sales and improved foreign exchange gains and losses due to the yen being weaker than in the same period of the previous year.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Financial Results Presentation for the Second Quarter of the Fiscal Year Ending February 2027 (42nd Fiscal Year) | RORZE CORPORATION (6323) timely disclosure | Komori